Weak sales, recalls and cost overruns have seen shares plummet by 77 per cent, while revenue and deliveries dropped by 7.5 percent and 11 per cent respectively compared to Q1.
|
Saturday, September 28, 2019
Subscribe to:
Post Comments (Atom)